Plant polyphenols as natural drugs for the management of Down syndrome and related disorders. (December 2016)
- Record Type:
- Journal Article
- Title:
- Plant polyphenols as natural drugs for the management of Down syndrome and related disorders. (December 2016)
- Main Title:
- Plant polyphenols as natural drugs for the management of Down syndrome and related disorders
- Authors:
- Vacca, Rosa Anna
Valenti, Daniela
Caccamese, Salvatore
Daglia, Maria
Braidy, Nady
Nabavi, Seyed Mohammad - Abstract:
- Highlights: Mitochondrial dysfunctions and oxidative stress are hallmarks in DS and in ID-related diseases. Polyphenols improve signalling pathways impaired in DS. Polyphenols target mitochondria and reduce oxidative stress. Polyphenols can suppress neuroinflammation and enhance memory and cognitive behaviour. Dietary polyphenols may be a therapeutic supplementation for DS handling. Abstract: Polyphenols are secondary metabolites of plants largely found in fruits, vegetables, cereals and beverages, and therefore represent important constituents of the human diet. Increasing studies have demonstrated the potential beneficial effects of polyphenols on human health. Extensive reviews have discussed the protective effects of polyphenols against a series of diseases such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders. Limited studies have investigated the potential therapeutic effects of these natural compounds on neurodevelopmental disorders associated with intellectual disability, such as Down syndrome (DS), for which mitochondrial dysfunctions and oxidative stress are hallmarks and contribute to the deleterious symptoms and cognitive decline. This review, starting from the structure, source, bioavailability and pharmacokinetics of relevant polyphenols, highlights recent studies on the effect and potential molecular mechanism(s) of action of the phenolic compounds epigallocatechin-3-gallate, resveratrol and hydroxytyrosol in restoringHighlights: Mitochondrial dysfunctions and oxidative stress are hallmarks in DS and in ID-related diseases. Polyphenols improve signalling pathways impaired in DS. Polyphenols target mitochondria and reduce oxidative stress. Polyphenols can suppress neuroinflammation and enhance memory and cognitive behaviour. Dietary polyphenols may be a therapeutic supplementation for DS handling. Abstract: Polyphenols are secondary metabolites of plants largely found in fruits, vegetables, cereals and beverages, and therefore represent important constituents of the human diet. Increasing studies have demonstrated the potential beneficial effects of polyphenols on human health. Extensive reviews have discussed the protective effects of polyphenols against a series of diseases such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders. Limited studies have investigated the potential therapeutic effects of these natural compounds on neurodevelopmental disorders associated with intellectual disability, such as Down syndrome (DS), for which mitochondrial dysfunctions and oxidative stress are hallmarks and contribute to the deleterious symptoms and cognitive decline. This review, starting from the structure, source, bioavailability and pharmacokinetics of relevant polyphenols, highlights recent studies on the effect and potential molecular mechanism(s) of action of the phenolic compounds epigallocatechin-3-gallate, resveratrol and hydroxytyrosol in restoring mitochondrial energy deficit and in reversing phenotypical alteration in DS. The clinical implications of plant polyphenol dietary supplements as therapeutic tools in managing DS and other intellectual disability-related diseases, is also discussed. … (more)
- Is Part Of:
- Neuroscience and biobehavioral reviews. Volume 71(2016)
- Journal:
- Neuroscience and biobehavioral reviews
- Issue:
- Volume 71(2016)
- Issue Display:
- Volume 71, Issue 2016 (2016)
- Year:
- 2016
- Volume:
- 71
- Issue:
- 2016
- Issue Sort Value:
- 2016-0071-2016-0000
- Page Start:
- 865
- Page End:
- 877
- Publication Date:
- 2016-12
- Subjects:
- AD Alzheimer's disease -- AMPK AMP activated protein kinase -- Aβ beta-amyloid -- CRM curcumin -- DS down syndrome -- DSCR1 down syndrome critical region 1 -- DYRK1A dual-specificity tyrosine (Y)-phosphorylation regulated kinase 1A -- EGCG epigallocatechin 3-gallate -- MeHT homovanillyl alcohol -- MAO monoamine oxidase -- HT hydroxytyrosol -- ID intellectual disability -- TFAM mitochondrial transcription factor A -- PGC-1α peroxisome proliferator-activated receptor gamma coactivator 1-alpha -- PKA protein kinase A -- QRC quercetin -- ROS reactive oxygen species -- RSV resveratrol -- RTT rett syndrome -- Sirt1 sirtuin-1 -- SOD1 superoxide dismutase 1 -- TBI traumatic brain injury
Polyphenols -- EGCG -- Resveratrol -- Hydroxytyrosol -- Down syndrome -- Mitochondria -- Neuroprotection -- Oxidative stress -- Intellectual disability -- Neurodevelopment diseases
Psychophysiology -- Periodicals
Human behavior -- Periodicals
Animal behavior -- Periodicals
Neurology -- Periodicals
Behavior -- Periodicals
Ethology -- Periodicals
Neurology -- Periodicals
Psychophysiologie -- Périodiques
Comportement humain -- Périodiques
Animaux -- Mœurs et comportement -- Périodiques
Neurologie -- Périodiques
Animal behavior
Human behavior
Neurology
Psychophysiology
Periodicals
Electronic journals
573.8 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01497634 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.neubiorev.2016.10.023 ↗
- Languages:
- English
- ISSNs:
- 0149-7634
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.561000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 445.xml